Søgeord

Søgning på udtrykket 'remdesivir' giver 24 resultater:


Dokumenter (2)

Antiviralt middel til behandling af hypoksisk COVID-19 pneumoni Version 1.7

Version 5.3 Denne vejledning er tiltænkt initial diagnostik og behandling af formodet COVID-19. Virussygdommen er først beskrevet i januar 2020, og der er endnu sparsom evidens på en række områder. Denne retningslinje vil løbende blive opdater…


Sider (0)


Kalender (0)


Nyt fra tidsskrifterne (10)

Der er mere end 10 resultater, måske du vil se flere resultater her?

Science Express TOC RSS Feed
21.09.2020
…n vitro. In human cells, LA supplementation synergizes with the COVID-19 drug remdesivir, suppressing SARS-CoV-2 replication. Our structure directly links LA and S, setting the stage for intervention strategies targeting LA binding by SARS-CoV-2.

BMJ Open Current Issue
21.09.2020
…sed between five arms: (1) a control group managed with SoC and four therapeutic arms with re-purposed antiviral agents: (2) remdesivir + SoC, (3) lopinavir/ritonavir + SoC, (4) lopinavir/ritonavir associated with interferon (IFN)-β–1a + SoC and (…

JAMA Current Issue
15.09.2020
This open-label randomized trial compares the effect of remdesivir (5 or 10 days) vs standard care on clinical status 11 days after treatment initiation among patients with confirmed SARS-CoV-2 infection hospitalized with moderate pneumonia (room air…

JAMA Current Issue
15.09.2020
…ting drastic public health measures and prompting a fervent search for effective treatments. The experimental antiviral drug remdesivir (manufactured by Gilead) was granted Emergency Use Authorization by the US Food and Drug Administration in May 202…

The American Journal of Tropical Medicine and Hygiene: Most Recent Articles
2.09.2020
…RS-CoV-2 that, as of July 12, 2020, has caused a reported 12,322,395 cases and 556,335 deaths. To date, only two treatments, remdesivir and dexamethasone, have demonstrated clinical efficacy through randomized controlled trials (RCTs) in seriously il…

AAC Accepts: Articles Published Ahead of Print
31.08.2020
Remdesivir has reported efficacy against SARS-CoV-2 in vitro and in vivo. Drug-drug interactions limit therapeutic options in transplant patients. Remdesivir and its metabolite GS-441524 are excreted principally in urine. In ICU settings, in which mu…

Clinical Infectious Diseases Advance Access
28.08.2020
…death (all p& 0.001). Many patients received investigational medications for treatment of COVID-19, including 48 patients on remdesivir and 4,232 on hydroxychloroquine.CONCLUSIONThis large observational cohort describes the clinical course and identi…

The Journal of Infectious Diseases Advance Access
26.08.2020
….2% to 1.9% (Table 1). Although the actual rates may be lower due to lack of universal testing, these risks are substantial. Remdesivir is the only antiviral that has a beneficial effect on coronavirus disease 2019 (COVID-19); it shortens length of s…

JAMA Current Issue
25.08.2020
This JAMA Live Highlights feature provides comments about the coronavirus 2019 pandemic from experts in clinical medicine, public health, and health policy expressed during livestream interviews with JAMA Network Editor in Chief Howard Bauchner, MD.

Wiley: Journal of Medical Virology: Table of Contents
19.08.2020
Journal of Medical Virology, Accepted Article.


Aktuelle smitsomme sygdomme (10)

Der er mere end 10 resultater, måske du vil se flere resultater her?

Medscape Infectious Diseases Headlines
31.08.2020
An earlier emergency use authorization from May allowed the drug to be used only for patients with severe COVID-19.

Medscape Infectious Diseases Headlines
25.08.2020
These are the coronavirus stories you need to know about today.

Medscape Infectious Diseases Headlines
25.08.2020
The drug's manufacturer is pushing the FDA to expand the emergency use authorization to full approval for all hospitalized with COVID-19. But some experts say there are too many unanswered questions.

Medscape Infectious Diseases Headlines
12.08.2020
The ACTT-3 randomized controlled trial is testing the safety and efficacy remdesivir in combination with the immunomodulator interferon beta-1a in hospitalized COVID-19 patients.

Medscape Infectious Diseases Headlines
8.07.2020
The coronavirus stories Medscape's editors around the globe think you need to know about today.

HealthMap Global Disease Alerts
3.07.2020
…nUSAThe United States has bought nearly all the available global supplies for the next 3 months of anti-viral drug remdesivir, one of 2 drugs that have proven to be effective against COVID-19. The US Department of Health Services (HHS) anno…

Medscape Infectious Diseases Headlines
30.06.2020
The coronavirus stories Medscape's editors around the globe think you need to know about today.

Medscape Infectious Diseases Headlines
17.06.2020
Hospitals across the United States currently have access to the remdesivir they need to treat patients. But it's unclear when the next shipment is coming.

Medscape Infectious Diseases Headlines
3.06.2020
The results may not immediately affect the use of the drug, however, given current FDA guidance, limited supplies, and the challenges of administering an intravenous drug.

Medscape Infectious Diseases Headlines
23.05.2020
The results of the trial that prompted Dr Anthony Fauci to call remdesivir the "standard of care" for COVID-19 were published on Friday.

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2020 Dansk Selskab for Infektionsmedicin

version: 2.7.1 ● design: C P Fischer

Side indlæst på 0,833 s

Cookies og privatliv